Agents of Endocarditis
Endocarditis, the inflammation of the heart’s inner lining (endocardium), including the valves, is a serious and life-threatening infection. Bacteremia is a major risk factor. The rapid and accurate identification of the causative agents is crucial for guiding appropriate antimicrobial therapy and improving patient outcomes
Common Agents of Endocarditis
Staphylococcus aureus
- Prevalence: The most common cause of endocarditis, particularly in intravenous drug users (IVDUs), patients with prosthetic valves, and healthcare-associated infections
- Characteristics: Often rapidly progressive, with severe valvular damage
- Virulence: Highly virulent, producing toxins and enzymes that contribute to tissue damage and spread
- Clinical Presentation: Fever, chills, new heart murmur, embolic events (e.g., stroke, pulmonary emboli), skin manifestations (e.g., petechiae, Osler’s nodes, Janeway lesions)
- Treatment: Requires aggressive antibiotic therapy, often combined with surgical intervention (e.g., valve replacement)
Coagulase-Negative Staphylococci (CoNS)
- Prevalence: Common cause, especially for prosthetic valve endocarditis, but also in native valve infections
- Characteristics: Often associated with indwelling devices (e.g., central venous catheters, pacemakers)
- Species: Most commonly, Staphylococcus epidermidis
- Clinical Presentation: Often a more indolent course than S. aureus, with fever, new heart murmur, and potentially embolic events
- Antibiotic Resistance: CoNS often exhibit antimicrobial resistance, especially to beta-lactam antibiotics, making treatment challenging
Streptococcus spp.
- Prevalence: Streptococcus species are a significant cause of endocarditis
-
Types
- Streptococcus viridans group: The most common Streptococcus species causing endocarditis. These are normal inhabitants of the oral cavity and upper respiratory tract
- Streptococcus bovis group: Associated with colon cancer and other gastrointestinal disorders
- Other Streptococci: including Streptococcus pneumoniae and Streptococcus pyogenes, are less common but can cause endocarditis
- Characteristics: Can cause both acute and subacute endocarditis. May be associated with dental procedures or other invasive procedures
- Clinical Presentation: Fever, new heart murmur, embolic events. Can cause a more gradual onset of symptoms than S. aureus
- Treatment: Typically responds well to penicillin-based antibiotics
Enterococcus spp.
- Prevalence: Important cause, especially in healthcare-associated endocarditis and IVDU
- Characteristics: Can cause both native and prosthetic valve endocarditis. Often associated with urinary tract infections (UTIs) and gastrointestinal infections
- Species: Primarily Enterococcus faecalis and Enterococcus faecium
- Antibiotic Resistance: Enterococcus species are often resistant to multiple antibiotics, including vancomycin (VRE), posing significant treatment challenges
- Clinical Presentation: Fever, new heart murmur, embolic events. Can cause a more indolent course
- Treatment: Requires combination antibiotic therapy, sometimes including agents like ampicillin, vancomycin, and aminoglycosides
Gram-Negative Bacteria
- Prevalence: Less common than gram-positive organisms, but are important causes of endocarditis
- Characteristics: Often associated with healthcare-associated infections, IVDU, and prosthetic valve infections
-
Types
- HACEK organisms: A group of fastidious gram-negative bacteria: Haemophilus spp., Aggregatibacter spp. (formerly Actinobacillus), Cardiobacterium hominis, Eikenella corrodens, and Kingella kingae
- Pseudomonas aeruginosa: A pathogen in IVDU and prosthetic valve endocarditis. Often difficult to treat due to antibiotic resistance
- Enterobacteriaceae (e.g., Escherichia coli, Klebsiella pneumoniae): Can cause endocarditis, particularly in patients with indwelling devices or other risk factors
- Clinical Presentation: Fever, new heart murmur, embolic events. Can cause a more acute or chronic course, depending on the organism
- Treatment: Antibiotic therapy typically includes broad-spectrum agents, with treatment tailored to the specific organism and its susceptibility profile
Fungi
- Prevalence: Uncommon, but cause significant morbidity and mortality
- Characteristics: Often associated with prosthetic valves, IVDU, prolonged antibiotic therapy, and immunocompromised patients
-
Types
- Candida spp.: The most common fungal cause of endocarditis
- Aspergillus spp.: Less common, but can cause aggressive infections
- Clinical Presentation: Fever, new heart murmur, embolic events. Can have a subacute or chronic course. May be difficult to diagnose
- Treatment: Requires antifungal therapy, often with surgical intervention
Less Common Agents of Endocarditis
-
Nutritionally Variant Streptococci (NVS)
- These are Streptococci that require pyridoxal (Vitamin B6) for growth
- They are difficult to identify by routine laboratory methods
- Brucella spp.: A zoonotic pathogen; endocarditis is rare but can occur
- Coxiella burnetii: Causes Q fever. Endocarditis can occur years after the initial infection
- Tropheryma whipplei: Causes Whipple’s disease, and endocarditis is a rare manifestation
- Bartonella spp.: Endocarditis is associated with Bartonella, particularly in patients with valvular heart disease
- Chlamydia psittaci: Causes psittacosis (parrot fever), and endocarditis is a rare complication
Additional Considerations
-
Culture-Negative Endocarditis
- In approximately 2.5-31% of cases, blood cultures are negative, despite clinical signs of endocarditis
- Reasons
- Antibiotic use before blood cultures
- Fastidious organisms (e.g., HACEK organisms, Brucella)
- Non-bacterial causes (e.g., fungal endocarditis, sterile endocarditis)
- Inadequate blood culture technique
- Diagnosis: Requires echocardiography and/or other imaging techniques, serological testing, and, in some cases, valve biopsy for definitive diagnosis
-
Prosthetic Valve Endocarditis (PVE)
- A major complication of prosthetic valve replacement
- Early PVE: Occurs within 60 days of surgery. Staphylococcus aureus and CoNS are the most common causes
- Late PVE: Occurs >12 months after surgery. Streptococci and Enterococci are more common causes
-
Infective Endocarditis (IE) vs. Non-Infective Endocarditis
- IE is caused by infection, whereas non-infective endocarditis is usually caused by a sterile vegetation
Key Terms
- Endocarditis: Inflammation of the inner lining of the heart (endocardium)
- Vegetation: An accumulation of platelets, fibrin, microorganisms, and inflammatory cells on the heart valves
- Bacteremia: The presence of bacteria in the bloodstream
- Prosthetic Valve Endocarditis (PVE): Endocarditis that occurs in patients with prosthetic heart valves
- Native Valve Endocarditis (NVE): Endocarditis that occurs in patients with their own, natural heart valves
- Staphylococcus aureus: A Gram-positive bacterium that can cause a wide range of infections, including endocarditis
- Coagulase-Negative Staphylococci (CoNS): A group of staphylococci that do not produce coagulase (e.g., Staphylococcus epidermidis)
- Streptococcus viridans group: A group of streptococci that are normal inhabitants of the oral cavity
- Enterococcus spp.: Gram-positive cocci that are common gut flora. E. faecalis and E. faecium are common causes of endocarditis
- HACEK organisms: A group of fastidious Gram-negative bacteria (Haemophilus spp., Aggregatibacter spp., Cardiobacterium hominis, Eikenella corrodens, and Kingella kingae)
- Fungal Endocarditis: Endocarditis caused by fungi (e.g., Candida spp., Aspergillus spp.)
- Embolic Events: Occurrences in which bacteria, fragments of vegetation, or other particles break away from the heart valves and travel through the bloodstream, potentially causing infection in other organs
- Antibiotic Resistance: The ability of bacteria to survive and multiply in the presence of antibiotics
- IVDU: Intravenous drug use
- Surgical Intervention: In endocarditis, this may include valve replacement or repair, debridement of infected tissue, and drainage of abscesses